Zhende Medical Co., Ltd.
603301
Rang in aandelen
#4846
Zhende Medical Co., Ltd. engages in the research and development, production,... Zhende Medical Co., Ltd. engages in the research and development, production, and sale of medical care and protective equipment in China and internationally. The company offers gauze swab, lap sponge, and fluff gauze swab; non-woven swab; PBT bandage, elastic bandage, crepe bandage, crochet bandage, selvedge bandage, under-cast padding, and fluff gauze roll; dressing set; first aid kit; cotton pad and applicator; and gauze roll and abdominal pad. It also provides surgical gown, scrub suit, warm-up jacket, surgical headwear, and isolation gown; Surgical drape; standard surgical pack and custom procedure pack; equipment cover; OP Tape, hand towel, and fluid collection pouch; latex surgical glove; CSR wrap; and warming blanket system. In addition, the company offers isolation gown, surgical cap, shoe cover, medical mask, and particular respirator; compression bandage and compression stocking; wound care products; pre-filled flush syringes; and ostomy and accessories. Further, it provides respiratory health, home cleaning, IP collaboration, nasal care, protective gear and assistive devices, and personal beauty products. Zhende Medical Co., Ltd. was incorporated in 1994 and is headquartered in Shaoxing, China.
Aandeelprijs
$11.60
Marktkapitalisatie
$3.06B
Verandering (1 dag)
2.99%
Verandering (1 jaar)
14.73%
Land
CN
Handel Zhende Medical Co., Ltd. (603301)
Categorie
Healthcare
Winst voor Zhende Medical Co., Ltd. (603301)
Winst in Jun 2026 TTM: $49.34M
Volgens de meest recente financiële verslagen van Zhende Medical Co., Ltd. bedraagt de huidige winst van het bedrijf $49.34M. In 2023 behaalde het bedrijf een winst van $30.92M, een daling ten opzichte van de winst van 2022, die $116.23M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Zhende Medical Co., Ltd. van 2014 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $49.34M | -24.26% |
| 2024 | $65.14M | 110.65% |
| 2023 | $30.92M | -73.39% |
| 2022 | $116.23M | -9.91% |
| 2021 | $129.01M | -76.15% |
| 2020 | $540.83M | 1,790.20% |
| 2019 | $28.61M | 29.86% |
| 2018 | $22.03M | -2.72% |
| 2017 | $22.65M | 57.83% |
| 2016 | $14.35M | 2.07% |
| 2015 | $14.06M | 258.39% |
| 2014 | $3.92M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $3.81B | 7,613.63% |
US
|
|
| $4.11B | 8,227.84% |
FR
|
|
| - | - |
JP
|
|
| $1.59B | 3,122.63% |
US
|
|
| - | - |
CH
|
